154 related articles for article (PubMed ID: 15808469)
21. Structure-activity study of the interaction of bioreductive benzoquinone alkylating agents with DNA topoisomerase II.
Hasinoff BB; Wu X; Begleiter A; Guziec LJ; Guziec F; Giorgianni A; Yang S; Jiang Y; Yalowich JC
Cancer Chemother Pharmacol; 2006 Jan; 57(2):221-33. PubMed ID: 16010589
[TBL] [Abstract][Full Text] [Related]
22. Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.
Suzuki K; Yahara S; Maehata K; Uyeda M
J Nat Prod; 2001 Feb; 64(2):204-7. PubMed ID: 11430001
[TBL] [Abstract][Full Text] [Related]
23. Solid phase combinatorial synthesis of benzothiazoles and evaluation of topoisomerase II inhibitory activity.
Choi SJ; Park HJ; Lee SK; Kim SW; Han G; Choo HY
Bioorg Med Chem; 2006 Feb; 14(4):1229-35. PubMed ID: 16242334
[TBL] [Abstract][Full Text] [Related]
24. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of DNA topoisomerases II and/or I by pyrazolo[1,5-a]indole derivatives and their growth inhibitory activities.
Umemura K; Mizushima T; Katayama H; Kiryu Y; Yamori T; Andoh T
Mol Pharmacol; 2002 Oct; 62(4):873-80. PubMed ID: 12237334
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
[TBL] [Abstract][Full Text] [Related]
27. Two new benzofurans from Gastrodia elata and their DNA topoisomerases I and II inhibitory activities.
Lee YK; Woo MH; Kim CH; Kim Y; Lee SH; Jeong BS; Chang HW; Son JK
Planta Med; 2007 Oct; 73(12):1287-91. PubMed ID: 17973203
[TBL] [Abstract][Full Text] [Related]
28. The dietary anticancer agent ellagic acid is a potent inhibitor of DNA topoisomerases in vitro.
Constantinou A; Stoner GD; Mehta R; Rao K; Runyan C; Moon R
Nutr Cancer; 1995; 23(2):121-30. PubMed ID: 7644381
[TBL] [Abstract][Full Text] [Related]
29. DNA binding properties of 9-substituted harmine derivatives.
Cao R; Peng W; Chen H; Ma Y; Liu X; Hou X; Guan H; Xu A
Biochem Biophys Res Commun; 2005 Dec; 338(3):1557-63. PubMed ID: 16288723
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of DNA topoisomerase I and II, and growth inhibition of MDA-MB-231 human breast cancer cells by bis-benzimidazole derivatives with alkylating moiety.
Bielawski K; Wołczyński S; Bielawska A
Pol J Pharmacol; 2004; 56(3):373-8. PubMed ID: 15215569
[TBL] [Abstract][Full Text] [Related]
31. Studies on cytotoxic, hydroxyl radical scavenging and topoisomerase inhibitory activities of extracts of Tabernaemontana divaricata (L.) R.Br. ex Roem. and Schult.
Thind TS; Agrawal SK; Saxena AK; Arora S
Food Chem Toxicol; 2008 Aug; 46(8):2922-7. PubMed ID: 18577413
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of topoisomerase II as pH-dependent modulators of etoposide-mediated cytotoxicity.
Langer SW; Schmidt G; Sørensen M; Sehested M; Jensen PB
Clin Cancer Res; 1999 Oct; 5(10):2899-907. PubMed ID: 10537359
[TBL] [Abstract][Full Text] [Related]
33. Induction of apoptosis by plumbagin through reactive oxygen species-mediated inhibition of topoisomerase II.
Kawiak A; Piosik J; Stasilojc G; Gwizdek-Wisniewska A; Marczak L; Stobiecki M; Bigda J; Lojkowska E
Toxicol Appl Pharmacol; 2007 Sep; 223(3):267-76. PubMed ID: 17618663
[TBL] [Abstract][Full Text] [Related]
34. 2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship.
Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong BS; Jeong TC; Lee CS; Lee ES
Bioorg Med Chem; 2007 Jul; 15(13):4351-9. PubMed ID: 17493824
[TBL] [Abstract][Full Text] [Related]
35. The influence of hyaluronan-CD44 interaction on topoisomerase II activity and etoposide cytotoxicity in head and neck cancer.
Wang SJ; Peyrollier K; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2007 Mar; 133(3):281-8. PubMed ID: 17372087
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, topoisomerase I inhibition and structure-activity relationship study of 2,4,6-trisubstituted pyridine derivatives.
Zhao LX; Moon YS; Basnet A; Kim EK; Jahng Y; Park JG; Jeong TC; Cho WJ; Choi SU; Lee CO; Lee SY; Lee CS; Lee ES
Bioorg Med Chem Lett; 2004 Mar; 14(5):1333-7. PubMed ID: 14980693
[TBL] [Abstract][Full Text] [Related]
37. Structural analysis of isosteviol and related compounds as DNA polymerase and DNA topoisomerase inhibitors.
Mizushina Y; Akihisa T; Ukiya M; Hamasaki Y; Murakami-Nakai C; Kuriyama I; Takeuchi T; Sugawara F; Yoshida H
Life Sci; 2005 Sep; 77(17):2127-40. PubMed ID: 15935396
[TBL] [Abstract][Full Text] [Related]
38. DNA topoisomerase I inhibitory alkaloids from Corydalis saxicola.
Cheng X; Wang D; Jiang L; Yang D
Chem Biodivers; 2008 Jul; 5(7):1335-44. PubMed ID: 18649321
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity.
Kim JS; Rhee HK; Park HJ; Lee IK; Lee SK; Suh ME; Lee HJ; Ryu CK; Choo HY
Bioorg Med Chem; 2007 Jan; 15(1):451-7. PubMed ID: 17035025
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, cytotoxic activities and structure-activity relationships of topoisomerase I inhibitors: indolizinoquinoline-5,12-dione derivatives.
Cheng Y; An LK; Wu N; Wang XD; Bu XZ; Huang ZS; Gu LQ
Bioorg Med Chem; 2008 Apr; 16(8):4617-25. PubMed ID: 18296054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]